High-dose vitamin D supplementation in multiple sclerosis: a systematic review of clinical effects and future directions
Authors:
- Nicholas AderintoNANicholas Aderinto
- Gbolahan OlatunjiGOGbolahan Olatunji
- Emmanuel KokoriEKEmmanuel Kokori
- Ikponmwosa Jude OgieuhiIOIkponmwosa Jude Ogieuhi
- Owolabi SamuelOSOwolabi Samuel
- Israel Charles AbrahamIAIsrael Charles Abraham
- Julia Kwape MimiJMJulia Kwape Mimi
- Aminnah OyesomiAOAminnah Oyesomi
- Yewande Abigail AdebayoYAYewande Abigail Adebayo
- Emmanuel EgbunuEEEmmanuel Egbunu
- Akinmeji AyodejiAAAkinmeji Ayodeji
Open Access
- 17 July 2024
- journal article
- review article
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-11
Abstract
Vitamin D deficiency is common in multiple sclerosis (MS) patients. This review explores the potential benefits and limitations of high-dose vitamin D supplementation in MS management. We reviewed relevant literature on the effects of high-dose vitamin D supplementation on relapse rates, disability progression, quality of life, and MRI markers of disease activity in MS patients. Additionally, we discussed the mechanisms by which vitamin D might influence MS, potential adverse effects, and future research directions. Studies suggest that high-dose vitamin D supplementation may reduce relapse rates and improve MRI markers of disease activity in MS. However, the evidence for its impact on disability progression and quality of life remains inconclusive. Vitamin D’s immunomodulatory properties are well-documented, and its potential for neuroprotection and neurogenesis warrants further investigation. High-dose vitamin D supplementation holds promise as a complementary or disease-modifying therapy for MS. However, further robust research is required to solidify its role in clinical practice. Exploring vitamin D’s multifaceted effects on the immune system, neuroprotection, and neurogenesis paves the way for novel therapeutic strategies to improve the lives of individuals with MS.Keywords
This publication has 41 references indexed in Scilit:
- Association between VDR polymorphisms and multiple sclerosis: systematic review and updated meta-analysis of case-control studiesNeurological Sciences, 2017
- Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM studyJournal of Neuroimmunology, 2016
- Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosisJournal of Neurology, 2015
- Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expressionLife Sciences, 2015
- Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-betaJournal of Neuroimmunology, 2015
- 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controlsJournal of Neuroimmunology, 2015
- Evidence for an Association Between Vitamin D and Multiple Sclerosis2014
- Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysisNeuroscience Letters, 2014
- Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosisAnnals of Neurology, 2012
- Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancerInternational Journal of Colorectal Disease, 2008